Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy

• Principais autores: Zerrin Sezgin-Bayindir (Autor), Sonia Losada-Barreiro (Autor), Carlos Bravo-Díaz (Autor), Matej Sova (Autor), Julijana Kristl (Autor), Luciano Saso (Autor)
• Formato: Livro
• Publicado em: MDPI AG, 2021-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The disadvantages of conventional anticancer drugs, such as their low bioavailability, poor targeting efficacy, and serious side effects, have led to the discovery of new therapeutic agents and potential drug delivery systems. In particular, the introduction of nano-sized drug delivery systems (NDDS...